Wuhan Keqian BiologyLtd Balance Sheet Health
Financial Health criteria checks 5/6
Wuhan Keqian BiologyLtd has a total shareholder equity of CN¥3.9B and total debt of CN¥58.3M, which brings its debt-to-equity ratio to 1.5%. Its total assets and total liabilities are CN¥4.4B and CN¥573.3M respectively. Wuhan Keqian BiologyLtd's EBIT is CN¥234.7M making its interest coverage ratio -2.9. It has cash and short-term investments of CN¥1.1B.
Key information
1.5%
Debt to equity ratio
CN¥58.28m
Debt
| Interest coverage ratio | -2.9x |
| Cash | CN¥1.07b |
| Equity | CN¥3.86b |
| Total liabilities | CN¥573.29m |
| Total assets | CN¥4.43b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688526's short term assets (CN¥2.4B) exceed its short term liabilities (CN¥485.3M).
Long Term Liabilities: 688526's short term assets (CN¥2.4B) exceed its long term liabilities (CN¥88.0M).
Debt to Equity History and Analysis
Debt Level: 688526 has more cash than its total debt.
Reducing Debt: 688526's debt to equity ratio has increased from 0% to 1.5% over the past 5 years.
Debt Coverage: 688526's debt is well covered by operating cash flow (627.1%).
Interest Coverage: 688526 earns more interest than it pays, so coverage of interest payments is not a concern.